Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (95)

1

Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Abdizadeh, R. | Hadizadeh, F. | Abdizadeh, T.

2

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial

enthalten in: Influenza and other respiratory viruses | 2023

von Alotaibi, F. | Alharbi, N. | Rosen, L. | +25

3

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

enthalten in: JAMA | 2023

von Writing Committee for the REMAP-CAP Investigators | Higgins, A. | Berry, L. | +164

CommentIn: JAMA. 2023 Jan 3;329(1):25-27. - PMID 36525259

4

Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart Tissues

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2022

von Xu, H. | Liu, G. | Gong, J. | +11

5

Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Copertino, D. | Casado Lima, B. | Duarte, R. | +6

6

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE) : A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

enthalten in: PLoS medicine | 2022

von Lowe, D. | Brown, L. | Chowdhury, K. | +15

7

A systematic review and Bayesian network meta-analysis for comparative safety assessment of favipiravir interventions in hospitalized COVID-19 patients

enthalten in: Journal of infection in developing countries | 2022

von Yang, K. | Zeng, J. | Dai, W. | +2

8

Short-term Pregnancy Outcomes After Nirmatrelvir-Ritonavir Treatment for Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

enthalten in: Obstetrics and gynecology | 2022

von Loza, A. | Farias, R. | Gavin, N. | +3

9

Emerging Therapies for COVID-19 : The Value of Information From More Clinical Trials

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2022

von Dijk, S. | Krijkamp, E. | Kunst, N. | +3

10

High-cited favorable studies for COVID-19 treatments ineffective in large trials

enthalten in: Journal of clinical epidemiology | 2022

von Ioannidis, J.

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]